Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.
Stock data | 2024 | Change |
---|---|---|
Price | $15.25 | N/A |
Market Cap | $607.10M | N/A |
Shares Outstanding | 39.81M | N/A |
Employees | 63.00 | N/A |